How is the risk of postnatal HIV transmission minimized?

Updated: Mar 05, 2020
  • Author: Delia M Rivera, MD; Chief Editor: Russell W Steele, MD  more...
  • Print

Observational data and randomized clinical trials have demonstrated that infant prophylaxis (primarily using daily infant nevirapine) during breastfeeding significantly decreases the risk of postnatal transmission in breast milk and that maternal triple-drug prophylaxis during breastfeeding may likewise decrease postnatal infection. [20, 53] The results from a randomized, double-blind, placebo-controlled trial confirm that nevirapine prophylaxis via breastfeeding infants up to age 6 months provides protection from transmission of HIV-1 from mother to child. [54]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!